SSE: 1501 - Shanghai Kindly Medical Instruments Co., Ltd.

Yield per half year: 0%
Dividend yield: +1.00%
Sector: Healthcare

Shanghai Kindly Medical Instruments Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
5/10
31.97 55.91 -42.82% 0 0%
P/S 7.17 19.97 -64.09%
P/BV 2.77 3.58 -22.53%
P/FCF 0 76.13 -100%
Ev/Ebitda 22.03 16.62 32.52%
Ev/S 6.86 23.53 -70.84%
Ev/FCF 0 79.02 -100%
E/P 0.029 0.0219 32.14%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
27.31 -83.23 -132.81% 27.31 0%
ROE 8.95 6.09 46.92%
ROA 4.69 3.49 34.45%
ROIC 0 0 0%
ROS 22.48 -76.66 -129.32%
ROCE 0 1.78 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.305 0.6721 -54.62% 0.305 0%
Nеt Debt/Ebitda 0 -0.1931 -100%
Debt/Ratio 0 0.1003 -100%
Debt/Equity 0 0.4767 -100%
Debt/Net Income 0.3705 3.21 -88.46%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
2.5/10
1 0.3991 150.56% 0 0%
Number of years of dividend growth 0 0.9885 -100%
DSI 1 0.6935 44.2%
Average dividend growth 0 3.04 -100%
Average percentage for 5 years 0 1.4 -100%
Average percentage for payments 0 61.66 -100%
Difference from average difference in sector 0.6009

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
6/10
0 -9.28 -100%
Growth impulse Ebitda in 5 years 0 12.85 -100%
Growth impulse Net Income in 5 years 0 481.65 -100%
Growth impulse FCF in 5 years 0 188.69 -100%
Growth impulse EPS in 5 years 0 57.97 -100%
IP Score
5.7/10

Similar companies

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Haohai Biological Technology Co., Ltd.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Shanghai Pioneer Holding Ltd

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription